Page 70 - நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China gives conditional approval to its first COVID vaccine - The San Diego Union-Tribune

BEIJING Chinese health regulators said Thursday that they have given conditional approval to a COVID-19 vaccine developed by state-owned Sinopharm. The two-dose vaccine is the first approved for general use in China. The go-ahead comes as the country has begun to vaccinate 50 million people before the Lunar New Year holiday in February. Conditional approval means that research is still ongoing. The company will be required to submit follow-up data as well as reports of any adverse effects after the vaccine is sold on the market, Chen Shifei, deputy commissioner of the National Medical Products Administration, said at a news conference.

United arab emiratesShen boTao linaZheng zhongweiChen shifeiZeng yixinSinovac biotechInstitute of biological productsNational health commissionNational medical products administrationForeign ministryLunar new yearBeijing instituteBiological productsNational healthஒன்றுபட்டது அரபு அமீரகங்கள்

Tourism to Israel down 81 3% in 2020 -- ministry

1 shares The Tourism Ministry says 850,000 tourists visited Israel in 2020 down 81 percent from last year, amid the pandemic. The Dead Sea shore and hotels on October 18, 2020. (Menachem Lederman/Flash90) I m proud to work at The Times of Israel I’ll tell you the truth: Life here in Israel isn’t always easy. But it s full of beauty and meaning. I m proud to work at The Times of Israel alongside colleagues who pour their hearts into their work day in, day out, to capture the complexity of this extraordinary place. I believe our reporting sets an important tone of honesty and decency that s essential to understand what s really happening in Israel. It takes a lot of time, commitment and hard work from our team to get this right.

Israel generalAs sulaymaniyahUnited arab emiratesUnited statesUnited kingdomTel avivNew yorkDead seaNew zealandWestern australiaWhite houseDistrict of columbiaAurora medical centerNew south walesSouth walesRam shefa

Vaccine from China s Sinopharm is 79% effective, drug maker says

Vaccine from Chinaâs Sinopharm is 79% effective, drug maker says Updated December 31, 2020, 3:54 p.m. Email to a Friend Vaccine from the Beijing Biological Products Institute Co., a unit of state-owned Sinopharm in Beijing, will soon begin hitting the market.Zhang Yuwei/Associated Press TAIPEI â China on Thursday approved a coronavirus vaccine developed by Sinopharm, a day after the state-owned drug maker reported the shot was 79.3 percent effective, paving the way for millions of doses of Chinese vaccines to enter the global market. Regulators gave the green light to the two-shot vaccine from China National Biotec Group (CNBG), a Sinopharm subsidiary, an official with Chinaâs National Medical Products Administration said at a media briefing.

United statesUnited kingdomDoug fordRichard vautreyRod phillipsJens spahnBritish medical associationAssociated pressNew york timesInstitute of biological productsBritain national health serviceEuropean unionWashington postEuropean medicines agencyBeijing instituteBiological products

The Latest: Germany reports more than 1,000 deaths in a day

The Latest: Germany reports more than 1,000 deaths in a day
fairfieldcitizenonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fairfieldcitizenonline.com Daily Mail and Mail on Sunday newspapers.

San joaquin valleyUnited statesUnited arab emiratesUnited kingdomBaton rougeCzech republicT ai peiLos angeles countyJared polisJulia barnhill letlowAngela merkelChen shih chungLuke letlowMark ghalyAbu dhabiAndrew bautsch

China s Sinopharm Says its Vaccine 79% Effective Against Covid-19

China s Sinopharm Says its Vaccine 79% Effective Against Covid-19 A model of a coronavirus is displayed next to boxes for Covid-19 vaccines at an exhibit by Chinese pharmaceutical firm Sinopharm at the China International Fair for Trade in Services (CIFTIS) in Beijin. (AP Photo/Mark Schiefelbein) China has struggled to gain international trust for its vaccine candidates, hindered by a lack of transparency on test results. FOLLOW US ON: Beijing: Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79 percent effective, the Chinese pharma giant said Wednesday, lower than rival jabs developed by Pfizer-BioNTech and Moderna but a potential breakthrough in the battle to stem the pandemic in Asia.

United arab emiratesZhao lijianInstitute of biological productsBeijing instituteBiological productsஒன்றுபட்டது அரபு அமீரகங்கள்நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட்ஸ்பெய்ஜிங் நிறுவனம்உயிரியல் ப்ராடக்ட்ஸ்